CorMedix IncNASDAQ:CRMD
- LAST PRICE5.2850
- TODAY'S CHANGE (%)0.1150 (2.2244%)
- Bid / Lots5.2800/ 5
- Ask / Lots5.2900/ 10
- Open / Previous Close5.1300 / 5.1700
- Day Range
- 52 Week Range
- Volume285,152
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 25533 | 5.18 |
| 09:34 ET | 15073 | 5.13 |
| 09:38 ET | 6680 | 5.1399 |
| 09:39 ET | 6225 | 5.1301 |
| 09:41 ET | 3200 | 5.185 |
| 09:45 ET | 8126 | 5.185 |
| 09:48 ET | 3603 | 5.205 |
| 09:50 ET | 794 | 5.21 |
| 09:52 ET | 1400 | 5.228 |
| 09:54 ET | 2795 | 5.225 |
| 09:56 ET | 1000 | 5.235 |
| 09:57 ET | 2300 | 5.28 |
| 09:59 ET | 1180 | 5.28 |
| 10:01 ET | 1100 | 5.25 |
| 10:03 ET | 2980 | 5.27 |
| 10:06 ET | 500 | 5.2653 |
| 10:08 ET | 200 | 5.265 |
| 10:10 ET | 1100 | 5.275 |
| 10:12 ET | 1300 | 5.27 |
| 10:14 ET | 1614 | 5.25 |
| 10:15 ET | 600 | 5.27 |
| 10:19 ET | 403 | 5.275 |
| 10:21 ET | 900 | 5.27 |
| 10:24 ET | 400 | 5.25 |
| 10:28 ET | 2943 | 5.23 |
| 10:30 ET | 150 | 5.235 |
| 10:32 ET | 3173 | 5.23 |
| 10:33 ET | 1116 | 5.25 |
| 10:35 ET | 2300 | 5.24 |
| 10:37 ET | 1400 | 5.23 |
| 10:39 ET | 400 | 5.23 |
| 10:42 ET | 100 | 5.22 |
| 10:44 ET | 2376 | 5.205 |
| 10:46 ET | 1290 | 5.2 |
| 10:48 ET | 1606 | 5.2 |
| 10:50 ET | 1300 | 5.205 |
| 10:51 ET | 3213 | 5.195 |
| 10:53 ET | 1161 | 5.205 |
| 10:55 ET | 100 | 5.21 |
| 10:57 ET | 235 | 5.215 |
| 11:00 ET | 1100 | 5.205 |
| 11:02 ET | 500 | 5.2127 |
| 11:06 ET | 200 | 5.215 |
| 11:09 ET | 1675 | 5.215 |
| 11:11 ET | 11192 | 5.205 |
| 11:13 ET | 1500 | 5.2188 |
| 11:15 ET | 584 | 5.21 |
| 11:18 ET | 415 | 5.21 |
| 11:20 ET | 100 | 5.215 |
| 11:22 ET | 200 | 5.215 |
| 11:24 ET | 6001 | 5.2303 |
| 11:26 ET | 600 | 5.23 |
| 11:29 ET | 5553 | 5.2 |
| 11:31 ET | 300 | 5.19 |
| 11:33 ET | 200 | 5.18 |
| 11:36 ET | 888 | 5.165 |
| 11:38 ET | 987 | 5.18 |
| 11:40 ET | 200 | 5.17 |
| 11:42 ET | 500 | 5.175 |
| 11:44 ET | 2399 | 5.185 |
| 11:45 ET | 100 | 5.188 |
| 11:47 ET | 200 | 5.185 |
| 11:49 ET | 1600 | 5.2 |
| 11:51 ET | 1200 | 5.195 |
| 11:54 ET | 100 | 5.198 |
| 11:58 ET | 700 | 5.2 |
| 12:00 ET | 2724 | 5.185 |
| 12:02 ET | 100 | 5.185 |
| 12:03 ET | 1116 | 5.192 |
| 12:07 ET | 301 | 5.19 |
| 12:09 ET | 400 | 5.19 |
| 12:12 ET | 500 | 5.195 |
| 12:14 ET | 5930 | 5.195 |
| 12:18 ET | 300 | 5.21 |
| 12:20 ET | 1254 | 5.215 |
| 12:21 ET | 1950 | 5.23 |
| 12:23 ET | 100 | 5.23 |
| 12:27 ET | 369 | 5.225 |
| 12:32 ET | 100 | 5.225 |
| 12:34 ET | 100 | 5.22 |
| 12:36 ET | 408 | 5.21 |
| 12:39 ET | 200 | 5.21 |
| 12:41 ET | 100 | 5.215 |
| 12:43 ET | 200 | 5.215 |
| 12:45 ET | 800 | 5.22 |
| 12:50 ET | 1425 | 5.21 |
| 12:52 ET | 100 | 5.22 |
| 12:54 ET | 300 | 5.22 |
| 12:56 ET | 100 | 5.21 |
| 12:59 ET | 300 | 5.205 |
| 01:01 ET | 1274 | 5.1983 |
| 01:03 ET | 100 | 5.185 |
| 01:06 ET | 630 | 5.185 |
| 01:08 ET | 200 | 5.18 |
| 01:10 ET | 600 | 5.17 |
| 01:12 ET | 499 | 5.155 |
| 01:14 ET | 1826 | 5.175 |
| 01:15 ET | 151 | 5.175 |
| 01:17 ET | 685 | 5.165 |
| 01:19 ET | 3009 | 5.14 |
| 01:21 ET | 1900 | 5.145 |
| 01:24 ET | 1591 | 5.145 |
| 01:26 ET | 700 | 5.135 |
| 01:28 ET | 300 | 5.1299 |
| 01:32 ET | 431 | 5.135 |
| 01:33 ET | 13866 | 5.15 |
| 01:35 ET | 600 | 5.15 |
| 01:37 ET | 700 | 5.15 |
| 01:39 ET | 598 | 5.16 |
| 01:42 ET | 1481 | 5.1515 |
| 01:44 ET | 2200 | 5.15 |
| 01:46 ET | 100 | 5.155 |
| 01:48 ET | 6007 | 5.17 |
| 01:51 ET | 200 | 5.17 |
| 01:53 ET | 368 | 5.175 |
| 01:55 ET | 300 | 5.18 |
| 01:57 ET | 500 | 5.18 |
| 02:00 ET | 300 | 5.18 |
| 02:02 ET | 6724 | 5.19 |
| 02:04 ET | 6830 | 5.21 |
| 02:06 ET | 300 | 5.22 |
| 02:08 ET | 1323 | 5.225 |
| 02:09 ET | 700 | 5.2201 |
| 02:11 ET | 100 | 5.225 |
| 02:13 ET | 100 | 5.23 |
| 02:15 ET | 157 | 5.228 |
| 02:18 ET | 300 | 5.23 |
| 02:20 ET | 300 | 5.225 |
| 02:22 ET | 600 | 5.24 |
| 02:24 ET | 1695 | 5.255 |
| 02:26 ET | 2405 | 5.26 |
| 02:27 ET | 300 | 5.27 |
| 02:29 ET | 300 | 5.27 |
| 02:31 ET | 5082 | 5.285 |
| 02:33 ET | 400 | 5.28 |
| 02:36 ET | 1228 | 5.275 |
| 02:38 ET | 1100 | 5.28 |
| 02:40 ET | 400 | 5.285 |
| 02:42 ET | 300 | 5.285 |
Today
May 10, 2024
CorMedix Inc. to Participate in Two Upcoming Investor Conferences, from 8:30AM ET on Friday May 10, 2024 by Dow Jones
8:30AM ET on Friday May 10, 2024 by Dow Jones
May 9, 2024
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update, from 7:30AM ET on Thursday May 09, 2024 by Dow Jones
7:30AM ET on Thursday May 09, 2024 by Dow Jones*DJ CorMedix 1Q Loss/Shr 25c >CRMD, from 7:30AM ET on Thursday May 09, 2024 by Dow Jones
7:30AM ET on Thursday May 09, 2024 by Dow Jones
May 6, 2024
CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024, from 8:30AM ET on Monday May 06, 2024 by Dow Jones
8:30AM ET on Monday May 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 284.3M | -5.7x | --- |
Cipla Ltd | 13.0B | 0.0x | --- |
Zevra Therapeutics Inc | 201.7M | -3.7x | --- |
Dbv Technologies SA | 126.0M | -1.4x | --- |
Assembly Biosciences Inc | 73.9M | -1.2x | --- |
Incannex Healthcare Inc | 40.3M | -6.6x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Chief Executive Officer, Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Head of Clinical and Medical Affairs
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Commercial Officer
- Erin Mistry
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $284.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.74 |
EPS | $-0.93 |
Book Value | $1.28 |
P/E Ratio | -5.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
